Trials / Completed
CompletedNCT00979927
SPC3649 Multiple Dose Study in Healthy Volunteers
A Placebo-controlled Double-blind, Randomised, Multiple Dose, Dose Escalating Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPC3649
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Santaris Pharma A/S · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the safety and tolerability of SPC3649 given in multiple doses to healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPC3649 | 5 weekly doses |
| DRUG | saline | 5 weekly doses |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2009-09-18
- Last updated
- 2011-10-05
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00979927. Inclusion in this directory is not an endorsement.